BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 24670459)

  • 21. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
    Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
    Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases].
    Zheng SS; Xu X; Liang TB; Wang WL; Shen Y; Zhang M; Wu J; Lu AW; Shao ZX
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):450-4. PubMed ID: 15854372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria.
    Fan HL; Chen TW; Hsieh CB; Jan HC; His SC; De-Chuan C; Chu CH; Yu JC
    Am J Surg; 2010 Aug; 200(2):252-7. PubMed ID: 20122677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis.
    Sapisochin G; Castells L; Dopazo C; Bilbao I; Minguez B; Lázaro JL; Allende H; Balsells J; Caralt M; Charco R
    Ann Surg Oncol; 2013 Apr; 20(4):1194-202. PubMed ID: 22965574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
    Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
    Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cirrhosis and microvascular invasion predict outcomes in hepatocellular carcinoma.
    Barreto SG; Brooke-Smith M; Dolan P; Wilson TG; Padbury RT; Chen JW
    ANZ J Surg; 2013 May; 83(5):331-5. PubMed ID: 22943449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival.
    Poon RT; Fan ST; Lo CM; Liu CL; Wong J
    Ann Surg; 2007 Jan; 245(1):51-8. PubMed ID: 17197965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria.
    Tanaka H; Kubo S; Tsukamoto T; Shuto T; Takemura S; Yamamoto T; Okuda T; Kanazawa A; Hirohashi K
    Transplant Proc; 2005 Mar; 37(2):1254-6. PubMed ID: 15848687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.
    Zheng Z; Liang W; Milgrom DP; Zheng Z; Schroder PM; Kong NS; Yang C; Guo Z; He X
    Transplantation; 2014 Jan; 97(2):227-34. PubMed ID: 24142034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
    Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
    Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience.
    Lei JY; Wang WT; Yan LN
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):200-4. PubMed ID: 23995766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatocellular carcinoma within Milan criteria and beyond: outcomes of liver transplantation in a single Argentinian institution].
    Gruz F; Cleres M; Raffa S; Yantorno S; Santilli JP; Vigliano C; Schelotto PB; Gondolesi GE; Descalzi V
    Acta Gastroenterol Latinoam; 2013 Jun; 43(2):106-12. PubMed ID: 23940910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization.
    Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Suzuki T; Shimamura T; Furukawa H; Matsushita M; Todo S
    Ann Surg Oncol; 2009 Jun; 16(6):1560-71. PubMed ID: 19259739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL; Zang YJ; Chen XG; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absolute lymphocyte count recovery at 1 month after transplantation predicts favorable outcomes of patients with hepatocellular carcinoma.
    Zheng Z; Lin B; Zhang J; Yang Z; Xie H; Zhou L; Zhang M; Zheng S
    J Gastroenterol Hepatol; 2015 Apr; 30(4):706-11. PubMed ID: 25238140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
    Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
    Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.